Find Clinical Trials
Efficacy and safety of Valdoxan® given orally once a day for 24 weeks in patients with Major Depressive Disorder. Open, national, multicentric clinical trial for the evaluation of the antidepressant efficacy and tolerability of ValdoxanR and its additional clinical benefits for depressed patients.
Servier Protocol Code:
IC4-20098-542
Sponsor:
Servier Slovensko, spol. s.r.o.
EudraCT Number:
2009-010642-57
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Interventions / Treatments
The treatment(s) given to the participants in the study.
- Major Depressive Disorder
- AGOMELATINE
- S020098
Other study id numbers
Other identification numbers the study may be known by.
- IC4-20098-542